BIOXYTRAN INC
For the period ended Sep 30, 2024. Filed Oct 29, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Oct 29, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Unregistered Sales of Equity Securities and Use of Proceeds
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Unregistered sales of Preferred Stock issued during the reporting period:
| Date · # Shares · Amount · Price/Share · Type · Notice | ||||||
|---|---|---|---|---|---|---|
| 8/19/2024 | b | 776,817 | $353,840 | $0.456 | debt conversion | affiliate |
Unregistered sales of Common Stock issued during the reporting period:
| Date · # Shares · Amount · Price/Share · Type · Notice | ||||||
|---|---|---|---|---|---|---|
| 1/17/2024 | a | 333,333 | $45,000 | $0.135 | private placement | |
| 1/18/2024 | b | 3,703,704 | 500,000 | 0.135 | debt conversion | |
| 1/18/2024 | b | 3,599,289 | 485,904 | 0.135 | debt conversion | affiliate |
| 3/27/2024 | b | 3,705,808 | 385,404 | 0.104 | debt conversion | |
| 4/04/2024 | b | 1,000,000 | 104,000 | 0.104 | debt conversion | |
| 4/15/2024 | a | 173,077 | 18,000 | 0.104 | private placement | |
| 4/19/2024 | b | 250,000 | 32,125 | 0.129 | debt conversion | |
| 4/22/2024 | a | 194,553 | 25,000 | 0.128 | private placement | |
| 5/20/2024 | b | 1,027,397 | 150,000 | 0.146 | debt conversion | |
| a | The Company claims an exemption from the registration requirements of the Securities Act of 1933 (the “Securities Act”) for the private placement of these securities pursuant to Section 4(a)(2) of the Securities Act and/or Rule 506 of Regulation D promulgated under the Securities Act. |
|---|---|
| b | The Company claims an exemption from the registration requirements of the Securities Act pursuant to the Exchange Exemption in Rule 3(a)(9) of the Securities Act. |
| c | The Company claims an exemption from the registration requirements of the Securities Act pursuant to the Exchange Exemption under Rule 145 of the Securities Act. |
All funds received though these equity transactions have been used for general working capital expenses.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.